Gavin Choy
Impact in
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 8
- Lung Cancer Research Studies 4
-
- Epigenetics and DNA Methylation 6
- Cancer therapeutics and mechanisms 3
- Co-authors
- Pietro Taverna (15 shared papers)Mohammad Azab (12 shared papers)Sanjeev Redkar (11 shared papers)Laurence Z. Rubenstein (1 shared paper)Adam R. Karpf (2 shared papers)Elizabeth A. Griffiths (4 shared papers)Aram Oganesian (4 shared papers)Anthony W. Tolcher (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (6 papers)Blood (5 papers)Molecular Cancer Therapeutics (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Gavin Choy
38 papers receiving 386 citations
Peers
Comparison fields: 5 of 54
- Geriatrics and Gerontology 32
- Family Practice 12
- Hepatology 48
- Hematology 44
- Cancer Research 42
Countries citing papers authored by Gavin Choy
This map shows the geographic impact of Gavin Choy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Choy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Choy more than expected).
Fields of papers citing papers by Gavin Choy
This network shows the impact of papers produced by Gavin Choy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Choy. The network helps show where Gavin Choy may publish in the future.
Co-authors
The 25 scholars most cited alongside Gavin Choy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 82 | |
| 2 | 2013 | 60 | |
| 3 | 1997 | 42 | |
| 4 | 2014 | 27 | |
| 5 | 2012 | 25 | |
| 6 | 2004 | 22 | |
| 7 | 2011 | 21 | |
| 8 | 2004 | 12 | |
| 9 | 2017 | 11 | |
| 10 | 2010 | 9 | |
| 11 | 2006 | 8 | |
| 12 | 2018 | 7 | |
| 13 | 2012 | 7 | |
| 14 | 2012 | 6 | |
| 15 | 2013 | 6 | |
| 16 | 2010 | 5 | |
| 17 | Vinorelbine liposomes injection results in greater tumor drug exposure compared to conventional vinorelbine in tumor-bearing nude mice | 2007 | 5 |
| 18 | 2014 | 5 | |
| 19 | 2014 | 4 | |
| 20 | 2010 | 4 |
About Gavin Choy
Gavin Choy is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Epidemiology, having authored 40 papers that have together received 403 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Epigenetics and DNA Methylation (6 papers), Lung Cancer Treatments and Mutations (6 papers), Microtubule and mitosis dynamics (5 papers), Acute Myeloid Leukemia Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Geriatrics and Gerontology (32 citations), Family Practice (12 citations), Hepatology (48 citations), Hematology (44 citations) and Cancer Research (42 citations). Gavin Choy has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Pietro Taverna, Mohammad Azab, Sanjeev Redkar, Laurence Z. Rubenstein, Adam R. Karpf, Elizabeth A. Griffiths, Aram Oganesian, Anthony W. Tolcher, John F. Lyons and Fang Fang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Blood, Molecular Cancer Therapeutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.